Skip to content
Sign in

CVS · NYSE

CVS Health (CVS) Stock Price & Fundamentals

$416.63+1.10%+$4.55End-of-day price as of Oct 9, 2026

CVS Health (CVS) closed at $416.63 on Oct 9, 2026, up 1.10% from the previous close of $412.08.

Share price, past year

1Y +3.13%

52-week range $385.44 – $440.05. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$416.63
Sep 30, 2026$410.14
Aug 31, 2026$408.30
Jul 31, 2026$422.36
Jun 30, 2026$423.60
May 29, 2026$399.53
Apr 30, 2026$389.01
Mar 31, 2026$426.05
Feb 27, 2026$399.80
Jan 30, 2026$413.57
Dec 31, 2025$412.56
Nov 28, 2025$396.99
Oct 31, 2025$395.89

Key statistics

Market cap
$532.45B
P/E (TTM)
109.9
EPS (TTM)
$3.79
Revenue (TTM)
$415.09B
Net income (TTM)
$4.89B
Shares outstanding
1.3B
Dividend yield
0.64%
52-week range
$385.44 – $440.05

CVS Health's market cap is $532.45B, based on a share price of $416.63 and 1.3B shares outstanding as of Jun 30, 2026.

Financials

CVS Health reported revenue of $402.07B for fiscal 2025, up 7.85% from fiscal 2024.

CVS Health earned net income of $1.77B in fiscal 2025, a net margin of 0.4%.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
CVS Health annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$402.07B+7.9%$1.77B0.4%$1.39$7.81B
FY2024ended Dec 31, 2024$372.81B+4.2%$4.61B1.2%$3.66$6.33B
FY2023ended Dec 31, 2023$357.78B+11.0%$8.34B2.3%$6.47$10.40B
FY2022ended Dec 31, 2022$322.47B+10.4%$4.31B1.3%$3.26$13.45B
FY2021ended Dec 31, 2021$292.11B+8.7%$8.00B2.7%$6.02$15.75B
FY2020ended Dec 31, 2020$268.71B+4.7%$7.18B2.7%$5.46$13.43B
FY2019ended Dec 31, 2019$256.78B+32.0%$6.63B2.6%$5.08$10.39B
FY2018ended Dec 31, 2018$194.58B+5.3%−$594.00M−0.3%−$0.57$6.83B
FY2017ended Dec 31, 2017$184.79B+4.1%$6.62B3.6%$6.44$6.09B
FY2016ended Dec 31, 2016$177.55B—$5.32B3.0%$4.90$7.92B
CVS Health quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$106.10B$2.98B$2.31
Q1 FY2026ended Mar 31, 2026$100.43B$2.94B$2.30
Q4 FY2025ended Dec 31, 2025$105.69B$2.94B$2.31
Q3 FY2025ended Sep 30, 2025$102.87B−$3.98B−$3.13
Q2 FY2025ended Jun 30, 2025$98.92B$1.02B$0.80
Q1 FY2025ended Mar 31, 2025$94.59B$1.78B$1.41
Q4 FY2024ended Dec 31, 2024$97.71B$1.64B$1.30
Q3 FY2024ended Sep 30, 2024$95.43B$87.00M$0.07

Company profile

Name
CVS HEALTH Corp
Ticker
CVS
Exchange
NYSE
Industry (SEC SIC)
Retail-Drug Stores and Proprietary Stores
Headquarters
One Cvs Dr., Woonsocket, RI 02895
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0000064803

Recent SEC filings

Frequently asked questions

What is CVS Health's stock price?

CVS Health (CVS) closed at $416.63 on Oct 9, 2026, up 1.10% from the previous close of $412.08.

What is CVS Health's market cap?

CVS Health's market cap is $532.45B, based on a share price of $416.63 and 1.3B shares outstanding as of Jun 30, 2026.

How much revenue does CVS Health make?

CVS Health reported revenue of $402.07B for fiscal 2025, up 7.85% from fiscal 2024.

What is CVS's P/E ratio?

CVS Health's price-to-earnings ratio is 109.9, based on trailing twelve-month diluted EPS of $3.79.

Does CVS Health pay a dividend?

Yes. CVS Health declared $2.66 per share in dividends over the last four quarters, a yield of 0.64%.

Sources and methodology

Fundamentals come from CVS HEALTH Corp's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures